CannTrust Holdings Inc. (CNTTQ) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 0 out of 7 criteria passed.
Financials: revenue is $46M, +370.9%/yr average growth. Net income is $14M (loss), growing at -80.7%/yr. Net profit margin is -29.7% (negative). Gross margin is 79.9% (+20004829405.9 pp trend).
Balance sheet: total debt is $14M against $174M equity (Debt-to-Equity (D/E) ratio 0.08, conservative). Current ratio is 7.65 (strong liquidity). Debt-to-assets is 6.9%. Total assets: $202M.
Analyst outlook: 1 / 3 analysts rate CNTTQ as buy (33%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 50/100 (Partial), Future 20/100 (Fail), Income 10/100 (Fail).